# Treatment for Presumed Ocular Histoplasmosis

> **NCT01790893** · PHASE1,PHASE2 · UNKNOWN · sponsor: **John Kitchens, MD** · enrollment: 40 (estimated)

## Conditions studied

- Ocular Histoplasmosis

## Interventions

- **DRUG:** aflibercept

## Key facts

- **NCT ID:** NCT01790893
- **Lead sponsor:** John Kitchens, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01790893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01790893, "Treatment for Presumed Ocular Histoplasmosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01790893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*